Cleared Traditional

Apollo Balloon Dilatation Catheter (K153742) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K153742 · Brosmed Medical Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2016
Decision
224d
Days
Class 2
Risk

K153742 is an FDA 510(k) clearance for the Apollo Balloon Dilatation Catheter. Classified as Catheters, Transluminal Coronary Angioplasty, Percutaneous (product code LOX), Class II - Special Controls.

Submitted by Brosmed Medical Co., Ltd. (Dongguan, CN). The FDA issued a Cleared decision on August 8, 2016 after a review of 224 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5100 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Brosmed Medical Co., Ltd. devices

Submission Details

510(k) Number K153742 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 28, 2015
Decision Date August 08, 2016
Days to Decision 224 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
99d slower than avg
Panel avg: 125d · This submission: 224d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5100
Definition A Ptca Catheter Is A Device That Operates On The Principle Of Hydraulic Pressurization Applied Through An Inflatable Balloon Attached To The Distal End.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous

All 44
Devices cleared under the same product code (LOX) and FDA review panel - the closest regulatory comparables to K153742.
Pantera LEO
K163660 · Biotronik, Inc. · Jan 2017
Emerge PTCA Dilatation Catheter
K163174 · Boston Scientific Corporation · Dec 2016
Maverick XL Percutaneous Transluminal Coronary Angioplasty Monorail Dilatation Cathete
K163200 · Boston Scientific Corporation · Dec 2016
NC Quantum Apex PTCA Dilatation Catheter
K160823 · Boston Scientific Corporation · Jun 2016
Euphora Rapid Exchange Balloon Dilatation Catheter
K143480 · Medtronic, Inc. · Apr 2015
NC EUPHORA RAPID EXCHANGE BALLOON DILATATION CATHETER
K141090 · Medtronic, Inc. · Aug 2014